Related Experiment Video
Updated: Aug 6, 2026

09:39
Quantitative Immunofluorescence Assay to Measure the Variation in Protein Levels at Centrosomes
Published on: December 20, 2014
15.6K
Immunofluorescence-based Determination of Centrosome Number in Tissue Samples
Mengdie Wang1, Gregory C Rogers1,2, Anne E Cress1,2
1Cancer Biology Research Program/University of Arizona Cancer Center, Tucson, AZ, USA.
Bio-Protocol
|March 3, 2021
Summary
Quantifying centrosome numbers in single cancer cells is crucial for therapy development. This study presents an easy-to-perform protocol using immunofluorescence microscopy for accurate centrosome counting in FFPE tissues.
Area of Science:
- Cell Biology
- Cancer Research
- Microscopy
Background:
- Centrosome numerical abnormalities are common in various tumors, exhibiting significant heterogeneity.
- Centrosome amplification, the overproduction of centrosomes, is a unique characteristic of cancer cells and a potential therapeutic target.
Purpose of the Study:
- To develop and describe a reliable protocol for quantifying centrosome numbers at the single-cell level.
- To enable accurate assessment of centrosome abnormalities in formalin-fixed paraffin-embedded (FFPE) tissue samples.
Main Methods:
- Utilizing multiplexing antibodies to identify bona fide centrosomes and cell borders.
- Employing high-resolution immunofluorescent microscopy with Z-sectioning for single-cell analysis.
- Applying the protocol to diverse human tissue samples.
Main Results:
- Successfully quantified centrosome numbers on a single-cell level in FFPE tissue samples.
- Demonstrated the protocol's ease of use and applicability across various human tissues.
- Provided a method to address the need for single-cell centrosome quantification in cancer research.
Conclusions:
- The described protocol offers a straightforward and effective method for quantifying centrosome numbers in FFPE tissues.
- This technique facilitates the study of centrosome amplification and numerical abnormalities in cancer.
- The protocol supports the advancement of centrosome-targeting cancer therapies.

